triumph-1 retatrutide TRIUMPH-4. Retatrutide. A once-weekly triple agonist GIP + GLP-1 + glucagon. One molecule. Three switches. 28.7% body weight loss at 68 weeks. ~71 lbs gone. Knee pain down 75.8%. Systolic BP down Lilly Prepares for Retatrutide FDA

, Effect of Liraglutide 3.0 Mg in Individuals With Obesity and Moderate or Severe Obstructive Sleep Apnea: The SCALE Sleep Apnea Randomized Clinical Trial, International Journal of Obesity (London, England: 2005) 40, no

Management options may include dose adjustment, temporary treatment interruption, addressing contributing factors (such as optimizing management of gastrointestinal side effects), or considering alternative weight management strategies if symptoms persist and significantly impact quality of life

Some providers interviewed by CBS News argued that retatrutides clinical trial results are compelling enough to justify early use

doi: 10.1006/bbrc.2001.4885

One question is whether laser or light therapy is FDA-approved for neuropathy